Deuterium MRS for In Vivo Measurement of Lipogenesis in the Liver
NMR in Biomedicine · 2025
DOI: 10.1002/nbm.70014 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, 2025. Verfasst von Ayhan Gursan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Image Sciences, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Liver, Lipogenesis, Deuterium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NCI NIH HHS, NIH HHS, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Hepatic de novo lipogenesis (DNL) plays a key role in the pathogenesis of several metabolic diseases that affect the liver. In humans, the detection of deuterium ( 2 H) in triglycerides from very low density lipoprotein collected from blood after administration of deuterated water (D 2 O) is commonly used as an indirect estimate of hepatic DNL. Here, we tested in rats (1) the feasibility to detect 2 H‐labeling directly in liver lipids in vivo by using noninvasive 2 H MRS and (2) to what extent these results correlated with the gold standard measurement of DNL in excised liver tissue. To increase hepatic DNL, half of the animals ( n = 4) underwent a 7‐week dietary intervention in which fructose was provided in drinking water. Deuterium MRS data were acquired from a single voxel placed in the liver. In vivo 2 H MRS data showed 2 H‐labeling in the combined peak of methyl and methylene resonances after 1 week of administrati NBM_70014 on of 5% D 2 O as drinking water. DNL was calculated using 1 H and 2 H NMR data acquired from extracted lipids of excised liver tissue. The 2 H lipid level measured in vivo correlated with the ex vivo estimates of hepatic DNL ( r = 0.81, p = 0.016). These results demonstrate the feasibility of direct detection of deuterium labeling in liver lipids using localized 2 H MRS in vivo and indicate the potential of this approach to measure hepatic DNL. These initial observations provide a basis for the method to be translated and to develop noninvasive, quantitative measurements of hepatic DNL in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Image Sciences, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Radiology and Biomedical Imaging, Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA.
- Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
- Departments of Human Biology and Imaging, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, the Netherlands.
ORCID-Profile: Ayhan Gursan, Robin A de Graaf, Jeanine J Prompers, Henk M De Feyter
Förderung
- NCI NIH HHS
- NIH HHS
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Institutes of Health
Zitieren
APA
Gursan, A., de Graaf, R. A., Thomas, M. A., Prompers, J. J., & De Feyter, H. M. (2025). Deuterium MRS for In Vivo Measurement of Lipogenesis in the Liver. NMR in Biomedicine. https://doi.org/10.1002/nbm.70014
Vancouver
Gursan A, de Graaf RA, Thomas MA, Prompers JJ, De Feyter HM. Deuterium MRS for In Vivo Measurement of Lipogenesis in the Liver. NMR in Biomedicine. 2025. doi:10.1002/nbm.70014
BibTeX
@article{Gursan2025,
author = {Gursan, Ayhan and de Graaf, Robin A and Thomas, Monique A and Prompers, Jeanine J and De Feyter, Henk M},
title = {Deuterium MRS for In Vivo Measurement of Lipogenesis in the Liver},
journal = {NMR in Biomedicine},
year = {2025},
doi = {10.1002/nbm.70014}
}
EUVIMED